Clinical Trial Update: Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis [Phase 1]

View source ↗

Summary

A Phase I study evaluated continuous hyperthermic peritoneal perfusion with escalating doses of intraperitoneal platinum for gastrointestinal peritoneal carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• Intraperitoneal platinum (unspecified agent)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Peritoneal Neoplasms, Stomach Neoplasms | Phase 1 | Status: COMPLETED